Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme
Susan M. Chang(University of California, San Francisco), Patrick Y. Wen(Dana-Farber Cancer Institute), Timothy F. Cloughesy(University of California, Los Angeles), Harry S. Greenberg(University of Michigan–Ann Arbor), David Schiff(University of Virginia), Charles A. Conrad(The University of Texas MD Anderson Cancer Center), Karen Fink(The University of Texas at Austin), H. Ian Robins(University of Wisconsin System), Lisa De Angelis(Memorial Sloan Kettering Cancer Center), Jeffrey J. Raizer(Memorial Sloan Kettering Cancer Center), Kenneth R. Hess, Ken Aldape(The University of Texas MD Anderson Cancer Center), Kathleen R. Lamborn(University of California, San Francisco), John G. Kuhn(The University of Texas at San Antonio), Janet Dancey(National Institutes of Health), Michael D. Prados(University of California, San Francisco)
Cited by 402Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis